The Valuation Thesis: Is Eli Lilly Transitioning from Pharma Giant to AI Platform?
Market Reassessment of Eli Lilly While the current market narrative surrounding artificial intelligence is dominated by hardware manufacturers and cloud infrastructure providers, a growing contingent of investors is looking toward legacy industries to identify the next phase of AI-driven value creation. Specifically, market observers are increasingly scrutinizing Eli Lilly (NYSE: LLY) not merely as a […]











